Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-05-28
DOI
10.1093/ndt/gfaa117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial:post-hocanalysis of the Phase IIb MUSE trial of anifrolumab
- (2018) Eric F Morand et al. ANNALS OF THE RHEUMATIC DISEASES
- The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus
- (2018) Tineke Kraaij et al. JOURNAL OF AUTOIMMUNITY
- Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
- (2018) Liliana Michelle Gomez Mendez et al. Clinical Journal of the American Society of Nephrology
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2018) Scott A. Jenks et al. IMMUNITY
- B cell alterations during BAFF inhibition with belimumab in SLE
- (2018) Daniel Ramsköld et al. EBioMedicine
- Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab
- (2017) Federico Simonetta et al. JOINT BONE SPINE
- Successful use of sequential B-cell depletion therapy in lupus
- (2017) S Psarelis et al. LUPUS
- Update on Lupus Nephritis
- (2016) Salem Almaani et al. Clinical Journal of the American Society of Nephrology
- Current and Emerging Therapies for Lupus Nephritis
- (2016) S. V. Parikh et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The BAFFling effects of rituximab in lupus: danger ahead?
- (2016) Michael R. Ehrenstein et al. Nature Reviews Rheumatology
- Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus
- (2016) Michel W. P. Tsang-A-Sjoe et al. RHEUMATOLOGY
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
- (2015) Christopher M Tipton et al. NATURE IMMUNOLOGY
- Longer duration of B cell depletion is associated with better outcome
- (2015) Sofia Sapeta Dias et al. RHEUMATOLOGY
- The frequency and outcome of lupus nephritis: results from an international inception cohort study
- (2015) John G. Hanly et al. RHEUMATOLOGY
- Belimumab after rituximab as maintenance therapy in lupus nephritis
- (2014) T. Kraaij et al. RHEUMATOLOGY
- Dual B Cell Immunotherapy Is Superior to Individual Anti-CD20 Depletion or BAFF Blockade in Murine Models of Spontaneous or Accelerated Lupus
- (2014) WeiYu Lin et al. Arthritis & Rheumatology
- Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
- (2014) Arthritis & Rheumatology
- The Pathogenesis of Lupus Nephritis
- (2013) M. Lech et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
- (2012) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels
- (2012) Mark N. Lazarus et al. RHEUMATOLOGY
- B cell biomarkers of rituximab responses in systemic lupus erythematosus
- (2011) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study
- (2009) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells
- (2008) Yohei Saito et al. IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started